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Clathrin /?-light chain of rat liver coated vesicles is phosphorylated in vitro in the presence of poly(L-lysine) 
by an endogenous protein kinase which appears to be similar to casein kinase II. Clathrin b-light chain is 
also phosphorylated in vivo. After injection of PzP]phosphate into rats and preparation of purified coated 
vesicles in the presence of phosphatase inhibitors, electrophoretic analysis showed the presence of several 
labeled polypeptides including clathrin /34ight chain. A polypeptide of 50 kDa, which may correspond to 
the major polypeptide phosphorylated in vitro of coated vesicles, is also labeled in vivo. 
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1. INTRODUCTION 
Coated vesicles (CVs) play an important role in 
intracellular transport either in the internalization 
of external molecules and their receptors or in pro- 
tein maturation and secretion processes [ 1,2]. Each 
transport cycle between membrane-bound com- 
partments of eukaryotic cells requires coordinated 
coating and uncoating of the membrane by 
clathrin and its associated proteins. CVs are cage- 
like structures consisting of a membrane enclosed 
by a polyhedral protein lattice composed of 
clathrin, a 180 kDa polypeptide, associated with 
36 and 33 kDa polypeptides: the clathrin light 
chains. Minor polypeptides of 100 and 50 kDa 
have also been reported to be associated with the 
clathrin coat [3-51. The phosphorylation of CV 
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polypeptides was first reported in vitro in calf 
brain by Pauloin et al. [6], then confirmed in dif- 
ferent tissues including rat liver, showing essential- 
ly the same patterns. The major phosphopoly- 
peptide observed has a molecular mass of 50 kDa 
but several other proteins are also phosphorylated 
[7,8]. Pauloin and Jolles [9] have shown that in 
brain CVs, phosphorylation of the 50 kDa 
polypeptide is strongly stimulated in the presence 
of clathrin light chains. More recently, it has been 
shown that the clathrin P-light chain (33 kDa) is 
phosphorylated in vitro in the presence of 
polylysine or histones in calf brain CVs [ 10,111. 
The enzyme responsible for this phosphorylation 
has been identified as casein kinase (CK) II in calf 
brain [ 121. The light chain of clathrin CVs displays 
a heterogeneous structure in different tissues or 
species [ 131. Here, we have examined whether this 
chain is phosphorylated in other tissues than brain. 
We show that the P-light chain of clathrin is 
phosphorylated in vitro in CVs of rat liver. This 
phosphorylation seems to be a physiological func- 
tion of CVs, since it is observed in vivo: a labeled 
band corresponding to the&light chain of clathrin 
is observed after PAGE of liver CVs prepared 
from rats injected with 32P. 
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2. MATERIALS AND METHODS 0 
2. I , Materials Clathrin __t 
Buffalo rats were obtained from IRSC (Ville- 
juif). 2H~0 was obtained from CEA (Saclay, 
France); EGTA, Mes, Tris, NEM, PMSF, casein, 
heparin, histone, poly(L-lysine) (HBr, M, 17000), 
and unlabeled nucleotides were purchased from 
Sigma. EDTA and MSH were from Merck. 
[y-32P]ATP (spec. act. 3000-5000 mCi/mmol) 
was from DuPont (New England Nuclear). 
Acrylamide and other reagents for electrophoresis 
were from Biorad. 
2.2. Purification of CVs 
CVs were prepared from rat liver by a modifica- 
tion of the method of Nandi et al. 1141. All pro- 
cedures were carried out at 4°C. Livers from rats 
were excised, washed and homogenized in 2 vols of 
100 mM Mes buffer containing 250 mM sucrose, 
1 mM EGTA, 1 mM PMSF, 0.5 mM MgCl2 ad- 
justed to pH 6.5 (buffer A). The homogenate was 
centrifuged at 20000 x g for 50 min in a 60 Ti 
rotor. The supernatant was centrifuged at 100000 
x g for 60 min. The resulting pellet was homo- 
genized in buffer A, centrifuged for 10 min at 
10000 x g and the supernatant centrifuged for 
60 min at 140000 x g. This procedure was repeated 
once. The final pellet was resuspended in buffer A 
and the supernatant obtained after the low-speed 
centrifugation as above was layered over 8% 
sucrose/2H20 solution (with the same buffer salts 
as buffer A), then centrifuged for 2 h at 80000 x 
g at 20°C in an SW41 rotor. The pelleted fraction 
was resuspended in buffer A, homogenized and 
centrifuged for 10 min at 20000 x g. The superna- 
tant containing purified CVs was stored at - 80°C 
in aliquots. The purity of CV preparation was 
monitored by means of their relative content of 
clathrin (70% of total proteins) after SDS-PAGE 
and by electron microscopy analysis (fig. la,b). 
2.3. In vivo labeling of CVs 
Fig. 1. Electrophoretic pattern (a) and electron 
microscopy (b) of rat liver purified CVs. CVs purified as 
described in section 2 were analyzed by SDS-PAGE and 
electron microscopy (by courtesy of Dr Puvion, IRSC, 
3 mCi Na [32P]phosphate (Oris, France) was in- 
jected intraperitoneally into 12-week-old Buffalo 
rats. 2 h later animals were killed by decapitation 
and livers were excised, washed and homogenized 
in 2 vols buffer A without MgCl2 and containing 
phosphatase inhibitors: 10 mM PNPP, 20 mM 
EDTA, 10 mM Na, K tartrate, 25 mM NEM, 
25 mM Na pyrophosphate, 50 mM NaF and 
10 mM orthovanadate (buffer B). The homo- 
genate was then processed as described above. The 
cytosol fraction enriched in CVs was then boiled 
for 10 min and the supernatant containing the 
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clathrin &light chain was submitted to SDS-PAGE 
as described below. 
2.4. Preparation of casein kinases 
CK II was prepared according to Meggio et al. 
[15]. CK I was prepared as described by Pierre and 
Loeb [16]. 
2.5. In vitro phosphorylation assay 
The standard phosphorylation assay involved in- 
cubation of 2Opg CVs at 33°C with 0.5 ,&i of 
10 PM [Y-~~P]ATP in 50 mM Tris-HCl buffer (pH 
7.4), containing 10 mM MgClz in a total volume of 
35 ~1 for 3 min. Reactions were stopped by addi- 
tion of 27 ~1 Laemmli sample buffer [ 131 contain- 
ing 20% Triton X-100. After incubation for 
40 min at room temperature, samples were loaded 
on polyacrylamide slab gels containing 15% 
acrylamide, 0.1% bisacrylamide, 0.1% SDS ac- 
cording to Beemon and Hunter [17]. Elec- 
trophoresis was carried out at 4°C. Gels were 
stained with Coomassie blue 250, dried and sub- 
mitted to autoradiography using X-ray film at 
- 70°C. Protein content of samples was determin- 
ed according to Bradford [ 181. 
3. RESULTS AND DISCUSSION 
3.1. In vitro phosphorylation 
The addition of polylysine (50pg/ml) to highly 
purified rat liver CVs together with Mg’+ (10 mM) 
and [T-~~P]ATP promotes the phosphorylation of 
a 33 kDa polypeptide (fig.2a, lanes A,B). To a 
lesser extent, the same result is obtained in the 
presence of histone H 1, which contains numerous 
lysine residues (lane C). We have identified the 
33 kDa polypeptide as the clathrinfl-light chain by 
the following criteria: M, in SDS-PAGE, stability 
against boiling [llj (fig.2b) and association with 
the triskelions: when CVs, phosphorylated in the 
presence of polylysine, are dissociated in 1 M Tris 
(pH 8.6), the 33 kDa polypeptide is found after 
centrifugation in the supernatant fraction which 
contains the triskelions of clathrin; furthermore, 
after two-dimensional electrophoresis of CVs, no 
other polypeptide is found in the 33 kDa region 
(not shown). 
A casein kinase activity is present in rat liver 
CVs, as shown in fig.2. When CVs are incubated 
in the presence of exogenous casein, significant 
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Fig.2. (a) In vitro phosphorylation of 50 and 33 kDa CV 
polypeptides. 20 pg CVs were incubated as described in 
section 2 without (A) or with: 50,ug/ml of polylysine 
(B), 2OOpg/ml of histone Hl (C), 1 mg/ml of casein 
without (D) or with SOpg/mI of polylysine (E), 0.5 fig 
CK II without (F) or with 0.5 pg polylysine (G). (b) 
Thermostability of the 33 kDa “P-labeled polypeptide. 
20,~g CVs were phosphorylated as described in section 
2, boiled for 5 min (A) and centrifuged to remove 
denatured proteins. Electrophoresis and autoradiog- 
raphy of the supernatant is shown in B. 
phosphorylation of this protein is observed (lane 
D). This phosphorylation is increased in the 
presence of polylysine (lane E), suggesting that this 
kinase may be the CK II which is stimulated by 
polycations. The addition of purified CK II to 
CVs, in the presence of polylysine, provokes 
strong phosphorylation of the 33 kDa polypeptide 
145 
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(lane G) which is much stronger than that in the 
absence of exogenous CK II (lanes B,C). The 
presence of polylysine is an absolute requirement 
for this phosphorylation. If no polylysine is added, 
even in the presence of exogenous CK II, only 
weak phosphorylation of the 33 kDa polypeptide 
is detectable (lane F). 
Inhibitors of CK II are also potent inhibitors of 
clathrin P-light chain phosphorylation, as well as 
cold GTP (5 mM) or heparin (20 pg/ml). 
Moreover, CK I and CAMP-dependent protein 
kinase are ineffective (not shown). It appears that 
as in brain CVs [12], it is CK II-like activity pre- 
sent in CVs which phosphorylates the P-light chain 
of clathrin. Polylysine acts probably through in- 
teraction with the substrates, as suggested for 
other systems by Hathaway and Traugh [19]. 
When casein in excess (1 mg/ml) is added to CVs 
in the presence of polylysine, stimulation of the ca- 
sein phosphorylation is observed but no 
phosphorylation of the 33 kDa polypeptide is seen, 
suggesting that all the polylysine has been com- 
plexed with casein (lane E). 
3.2. In vivo phosphorylation 
As with every phosphorylation observed in 
vitro, phosphorylation of the 33 kDa polypeptide 
may be artificial. CK II is found in CVs but its 
presence may be due to an artefact of the prepara- 
tion or the conditions of incubation (pH 7.5, 
10 mM Mg*+), although improbable, may not cor- 
respond to the physiological condition of CVs in 
the cell. 
In order to ascertain that this phosphorylation is 
physiological, Na[32P]phosphate was injected into 
rats. Liver CVs were purified in the presence of 
phosphatase inhibitors as described in section 2, 
and phosphorylation of CV polypeptides was 
analyzed by PAGE. 
Fig.3 shows that among several labeled polypep- 
tides, a 33 kDa polypeptide is clearly visible (lane 
A). This species is heat stable, since it is present in 
the supernatant of CVs after boiling (lane B), sug- 
gesting strongly that it is the P-light chain of 
clathrin (see section 3.1). It has been reported that 
light chains may contain tightly bound nucleotides 
[20]. Treatment of the gels with hot PCA, which 
hydrolyses nucleotides, eliminates the possibility 
that labeling of the 33 kDa polypeptide is 
associated with nucleotides. The 110 kDa protein, 
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Fig.3. In vivo phosphorylation of rat liver CVs. Liver 
CVs were purified from 32P-injected rats and CVs were 
analyzed by SDS-PAGE. After Coomassie blue staining, 
the gels were further incubated in 5% PCA at 95°C for 
15 min in order to hydrolyze nucleic acids and 
nucleotides which can contaminate CVs. 
which is part of a complex also containing the 
50 kDa protein that is the major protein 
phosphorylated in vitro (fig.2), has been shown to 
be phosphorylated in vivo in CVs of cultured rat 
neurons [21]. A band corresponding precisely to a 
50 kDa protein is clearly visible, but further iden- 
tification is necessary. A strongly phosphorylated 
protein of 90 kDa is partially thermostable and re- 
mains to be identified as well as the 80, 70, 45 and 
25 kDa proteins. 
The addition of several protein phosphatase in- 
hibitors to buffer during the preparation of CVs is 
an essential requirement for obtaining efficient in 
vivo phosphorylation of CV polypeptides. When 
in vivo phosphorylation experiments were carried 
out in the presence of only NaF, the most common 
phosphatase inhibitor, no reproducible labeling of 
the polypeptides described above was observed. 
On the other hand, very rapid dephosphorylation 
activity takes place in vitro when rat liver CVs are 
incubated in the presence of liver homogenate or 
cytosol prepared in the absence of phosphatase in- 
hibitors (fig.4, lanes A-C). Several known 
phosphatase inhibitors have been assayed. The 
results show (fig.4, lanes D-F) that the most effi- 
cient inhibition of phosphatase activities was ob- 
tained by using a complete cocktail of inhibitors as 
described in section 2. 
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Fig.4. In vitro dephosphorylation of rat liver CVs by 
cytosol. Rat liver CVs were phosphorylated in vitro as 
described in section 2. Cold ATP (10d3 M) was added 
after 3 min incubation. This masks, by isotopic dilution 
of labeled [Y-~~P]ATP, subsequent phosphorylation 
permitting one to follow dephosphorylation. At the 
same time, cytosol [l mg/ml of protein in either buffer 
A (standard CV preparation buffer)] or buffer B 
[containing phosphatase inhibitors (see section 2)] was 
added and aliquots were pipetted after 0, 5 and 15 min 
and submitted to SDS-PAGE analysis. Lanes - (A-C) 
buffer A: 0, 5, 15 min; (D-F) buffer B: 0, 5, 15 min. 
3.3. Conclusion 
In summary, we have shown for the first time 
that clathrin P-light chain is phosphorylated in 
vivo. Our results show that phosphorylation of the 
observed 33 kDa polypeptide in vitro, in brain CVs 
[lo-121 as well as in rat liver, as demonstrated 
here, corresponds to a physiological reality. In 
vitro, P-light chain is phosphorylated by a CK II 
present in CVs. It is likely to be the same in vivo. 
Analysis of the sites phosphorylated in vivo and in 
vitro would be required to demonstrate this fact. 
In brain, P-light chain is phosphorylated in vitro 
on serine residues [12]. CK II phosphorylates 
preferentially acidic amino acid sequences of type 
SEEE: serine followed by a cluster of acidic amino 
acids such as glutamic acid [22]. The complete 
amino acid sequence of the P-light chain of 
clathrin from brain and lymphocytes has been 
recently determined [23]. Moreover, the amino 
acid sequence of exposed region of the P-light 
chain has been also determined in native triskelions 
and CVs [24]. From these results, one may suggest 
that the Ser 188, followed by two glutamic acids, 
can be the phosphorylation site, since it is located 
in the exposed region (158-208) of the P-light 
chain and that this sequence is common to brain 
and other tissues. The P-light chain from brain 
seems to be different from light chains from other 
tissues. Phosphorylation of the &light chain could 
correspond to a functional difference between 
triskelions and P-light chains, respectively. 
Clathrin heavy chains (180 kDa) are strongly con- 
served between species whereas a number of 
variants of clathrin light chains (33 and 36 kDa) 
have been reported [ 131. The fact that in both calf 
brain and rat liver, the 33 kDa clathrin P-light 
chain, in spite of its variability, is phosphorylated 
by the same kinase favors a possible physiological 
significance of this phosphorylation. 
The light chains have been proposed as playing 
a regulatory role in CV function. They stimulate 
phosphorylation of the 50 kDa protein [9] and are 
required for activity of the uncoating ATPase [25]. 
They have also been conjectured as modulating 
clathrin interaction with membranes [26,27]. Fur- 
ther investigation will elucidate whether phos- 
phorylation of thefl-light chain may modify one or 
several of these roles. 
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